Vimarsana
Biggest News Aggregation in the World

Sanjay Mathew News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sanjay Mathew. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sanjay Mathew Today - Breaking & Trending Today

CNNW New Day Weekend With Victor Blackwell And Christi Paul May 3, 2020 - Vimarsana News

CNNW New Day Weekend With Victor Blackwell And Christi Paul May 3, 2020

This is new day weekend with Victor Blackwell and christi paul. Beautiful downtown atlanta this morning. Good morning to you. So across the country, there is this, the reality, of balancing these two priorities, christi. Yeah. A growing anxiety and this unprecedented top crisis thats unfolding. Here in the United States, we know more than 66,000 people have died because of the coronavirus. More than 14 of them died just yesterday. More states are on a steady march to reopen in the meantime, that theyre enforcing safety measure, wearing masks, social distancing. My next sunday, more than 40 sta...

Highlights From the American College of Neuropsychopharmacology Annual Meeting - Vimarsana News

Highlights From the American College of Neuropsychopharmacology Annual Meeting

Psychiatric Times highlighted takeaways from the 2023 American College of Neuropsychopharmacology Annual Meeting in our February issue. Don't miss out on these important conference clinical pearls!

Health Beat: Ketamine works on treatment-resistant depression - Vimarsana News

Health Beat: Ketamine works on treatment-resistant depression

Two hundred eighty million people with depression live in a world devoid of color, with little hope of change. Most are prescribed anti-depressants, but researchers seeking alternatives just tested IV

Source: wfmz.com
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q3 2023 Earnings Call Transcript - Vimarsana News

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q3 2023 Earnings Call Transcript

Operator: Hello, thank you for standing by. And welcome to Xenon Pharmaceuticals Incorporated Third Quarter 2023 Earnings Conference Call.

FDA Approves Gepirone (Exxua) for Major Depressive Disorder - Vimarsana News

FDA Approves Gepirone (Exxua) for Major Depressive Disorder

Gepirone, sold under the brand name Exxua, does not cause sexual dysfunction or weight gain, unlike other antidepressants.